[{"address1": "21925 W. Field Parkway", "address2": "Suite 235", "city": "Deer Park", "state": "IL", "zip": "60010-7278", "country": "United States", "phone": "847 787 7361", "website": "https://www.etonpharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-400 for treating adrenal insufficiency; ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.", "fullTimeEmployees": 31, "companyOfficers": [{"maxAge": 1, "name": "Mr. Sean E. Brynjelsen", "age": 52, "title": "President, CEO & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 1116640, "exercisedValue": 0, "unexercisedValue": 16187572}, {"maxAge": 1, "name": "Mr. James R. Gruber CPA", "age": 52, "title": "CFO, Treasurer & Secretary", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 647849, "exercisedValue": 0, "unexercisedValue": 1195594}, {"maxAge": 1, "name": "Mr. David C. Krempa", "age": 35, "title": "Chief Business Officer", "yearBorn": 1989, "fiscalYear": 2024, "totalPay": 647849, "exercisedValue": 0, "unexercisedValue": 4872540}, {"maxAge": 1, "name": "Ms. Ipek  Erdogan-Trinkaus", "age": 42, "title": "Chief Commercial Officer", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 435943, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Danka  Radosavljevic", "title": "Executive Vice President of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Grossenbach", "title": "Senior Vice President of Sales Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 16.3, "open": 16.25, "dayLow": 16.25, "dayHigh": 16.65, "regularMarketPreviousClose": 16.3, "regularMarketOpen": 16.25, "regularMarketDayLow": 16.25, "regularMarketDayHigh": 16.65, "payoutRatio": 0.0, "beta": 1.164, "forwardPE": 31.056604, "volume": 241369, "regularMarketVolume": 241369, "averageVolume": 292804, "averageVolume10days": 360160, "averageDailyVolume10Day": 360160, "bid": 16.33, "ask": 16.58, "bidSize": 1, "askSize": 1, "marketCap": 441416608, "fiftyTwoWeekLow": 11.09, "fiftyTwoWeekHigh": 23.0, "allTimeHigh": 23.0, "allTimeLow": 1.95, "priceToSalesTrailing12Months": 6.2776127, "fiftyDayAverage": 18.7176, "twoHundredDayAverage": 16.4208, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 435172640, "profitMargins": -0.09503, "floatShares": 17973112, "sharesOutstanding": 26817535, "sharesShort": 2920610, "sharesShortPriorMonth": 3372905, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.1089, "heldPercentInsiders": 0.04388, "heldPercentInstitutions": 0.66264, "shortRatio": 10.79, "shortPercentOfFloat": 0.1145, "impliedSharesOutstanding": 26817536, "bookValue": 0.862, "priceToBook": 19.095127, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -6682000, "trailingEps": -0.26, "forwardEps": 0.53, "enterpriseToRevenue": 6.189, "enterpriseToEbitda": 92.178, "52WeekChange": 0.35494602, "SandP52WeekChange": 0.09209216, "quoteType": "EQUITY", "currentPrice": 16.46, "targetHighPrice": 35.0, "targetLowPrice": 26.0, "targetMeanPrice": 30.0, "targetMedianPrice": 29.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 37121000, "totalCashPerShare": 1.384, "ebitda": 4721000, "totalDebt": 30877000, "quickRatio": 1.136, "currentRatio": 1.63, "totalRevenue": 70316000, "debtToEquity": 133.516, "revenuePerShare": 2.633, "returnOnAssets": 0.01255, "returnOnEquity": -0.34173, "grossProfits": 39789000, "freeCashflow": -162625, "operatingCashflow": 21310000, "revenueGrowth": 1.175, "grossMargins": 0.56586, "ebitdaMargins": 0.067140006, "operatingMargins": -0.00174, "financialCurrency": "USD", "symbol": "ETON", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Eton Pharmaceuticals, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1542119400000, "postMarketChangePercent": 0.0, "postMarketPrice": 16.46, "postMarketChange": 0.0, "regularMarketChange": 0.16, "regularMarketDayRange": "16.25 - 16.65", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 292804, "fiftyTwoWeekLowChange": 5.369999, "fiftyTwoWeekLowChangePercent": 0.4842199, "fiftyTwoWeekRange": "11.09 - 23.0", "fiftyTwoWeekHighChange": -6.540001, "fiftyTwoWeekHighChangePercent": -0.28434786, "fiftyTwoWeekChangePercent": 35.494602, "earningsTimestamp": 1762462800, "earningsTimestampStart": 1762462800, "earningsTimestampEnd": 1762462800, "earningsCallTimestampStart": 1762464600, "earningsCallTimestampEnd": 1762464600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.26, "epsForward": 0.53, "epsCurrentYear": 0.39, "priceEpsCurrentYear": 42.205128, "fiftyDayAverageChange": -2.2576008, "fiftyDayAverageChangePercent": -0.1206138, "twoHundredDayAverageChange": 0.03919983, "twoHundredDayAverageChangePercent": 0.0023872058, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1763759404, "regularMarketTime": 1763758801, "exchange": "NGM", "messageBoardId": "finmb_435353222", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "longName": "Eton Pharmaceuticals, Inc.", "regularMarketChangePercent": 0.981594, "regularMarketPrice": 16.46, "displayName": "Eton Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-22"}]